[HTML][HTML] Microbiota-gut-brain Axis Dysregulation in Alzheimer's disease: Multi-pathway effects and therapeutic potential

L Qu, Y Li, F Liu, Y Fang, J He, J Ma, T Xu… - Aging and …, 2024 - ncbi.nlm.nih.gov
An essential regulator of neurodegenerative conditions like Alzheimer's disease (AD) is the
gut microbiota. Alterations in intestinal permeability brought on by gut microbiota …

Friends and Foes: The Ambivalent Role of Autophagy in HIV-1 Infection

S Klute, KMJ Sparrer - Viruses, 2024 - mdpi.com
Autophagy has emerged as an integral part of the antiviral innate immune defenses,
targeting viruses or their components for lysosomal degradation. Thus, successful viruses …

Contemporary Antiretroviral Therapy Dysregulates Iron Transport and Augments Mitochondrial Dysfunction in HIV-Infected Human Microglia and Neural-Lineage …

H Kaur, P Minchella, D Alvarez-Carbonell… - International Journal of …, 2023 - mdpi.com
HIV-associated cognitive dysfunction during combination antiretroviral therapy (cART)
involves mitochondrial dysfunction, but the impact of contemporary cART on chronic …

[HTML][HTML] Non-human primate models to investigate mechanisms of infection-associated fetal and pediatric injury, teratogenesis and stillbirth

M Li, A Brokaw, AM Furuta, B Coler… - Frontiers in …, 2021 - frontiersin.org
A wide array of pathogens has the potential to injure the fetus and induce teratogenesis, the
process by which mutations in fetal somatic cells lead to congenital malformations. Rubella …

Microglia: the real foe in HIV-1-associated neurocognitive disorders?

A Borrajo López, MA Penedo, T Rivera-Baltanas… - Biomedicines, 2021 - mdpi.com
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …

Neuropathogenesis of HIV and emerging therapeutic targets

A Siddiqui, C He, G Lee, A Figueroa… - Expert opinion on …, 2022 - Taylor & Francis
Introduction HIV infection causes a wide range of neurological complications, many of which
are among the most common complications of chronic HIV infection in the era of combined …

PPAR agonists for the treatment of neuroinflammatory diseases

C Titus, MT Hoque, R Bendayan - Trends in Pharmacological Sciences, 2023 - cell.com
Peroxisome proliferator-activated receptors [PPARs; PPARα, PPARβ/δ (also known as
PPARδ), and PPARγ] widely recognized for their important role in glucose/lipid homeostasis …

Drug transport in the brain

V Sangha, EI Williams, PT Ronaldson… - … and role in drug …, 2022 - Wiley Online Library
In the central nervous system (CNS), the effective delivery of pharmacological agents
remains limited by several brain barriers [ie, the blood–brain barrier (BBB), blood …

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

A Borrajo, D Pérez-Rodríguez… - International Journal of …, 2023 - mdpi.com
HIV-associated neurocognitive disorders (HANDs) still persist despite improved life
expectancy, reduced viral loads, and decreased infection severity. The number of patients …

SERPIN-Derived Small Peptide (SP16) as a Potential Therapeutic Agent against HIV-Induced Inflammatory Molecules and Viral Replication in Cells of the Central …

Y Soler, M Rodriguez, D Austin, C Gineste, C Gelber… - Cells, 2023 - mdpi.com
Despite the success of combined antiretroviral therapy (cART) increasing the survival rate in
human immunodeficiency virus (HIV) patients, low levels of viremia persist in the brain of …